PULMONARY MICROEMBOLI: THE ROLE OF OXYGEN RADICALS
肺微栓塞:氧自由基的作用
基本信息
- 批准号:3087164
- 负责人:
- 金额:$ 7.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-07-01 至 1989-06-30
- 项目状态:已结题
- 来源:
- 关键词:adult respiratory distress syndrome allopurinol catalase dimethylsulfoxide dogs electron microscopy enzyme mechanism free radicals granulocytopenia membrane permeability microscopy perfusion protective chemical group pulmonary circulation obstruction radiotracer respiratory airway pressure spectrometry superoxide dismutase superoxides technetium thiourea thromboembolism xanthine dehydrogenase xanthine oxidase
项目摘要
The Adult Respiratory Distress Syndrome (ARDS) is characterized initially
by increased permeability of the pulmonary microvasculature. In ARDS there
appears to be a potential involvement of leukocytes, platelets, oxygen
radicals, prostaglandins, complement activation, and intravascular
coagulation and fibrinolysis. The observation of both platelet-fibrin
plugs and leukostatic plugs in the lungs of man and experimental animals
has focused attention on microemboli, and has led to their use of
experimental models of acute lung injury. Although the role of superoxide
and other oxygen radicals has been described in oxygen toxicity, their role
in the injury due to pulmonary microemboli has received little attention
and is the overall objective of the proposed research.
The isolated, perfused dog lung label will be the basic experimental
preparation. The advantages of this preparation are 1) it is perfused with
whole blood with all of its constituents, 2) the weight of the lobe is
continuously monitored and specified indices of microvascular permeability
(Kf an Pci) can be calculated, and 3) arterial, venous, and airway
pressures can be adjusted independently to maintain the lobe in Zone 3.
This preparation will also extend the observations regarding the effects of
microemboli previously made in intact lung preparations.
The specific aims are 1) to characterize the changes in permeability,
vascular pressures, and cellular components of blood following microemboli,
2) to determine the protective effects of oxygen scavengers - superoxide
dismutase (SOD), catalase (CAT), dimethylthiourea (DMTU), and
dimethylsulfoxide (DMSO), 3) to describe the protective effects of
granulocytopenia, 4) to observe the effects of allopurinol pretreatment and
to correlate them with tissue levels of xanthine oxidase, and 5) to
characterize the direct effects of oxygen radicals on the lung and the
protective effects of oxygen scavengers. The lungs will be embolized with
air bubbles (less than 1 mm in diameter), glass beads (50, 200, and 500
microns in diameter), and leukocyte aggregates (induced by complement
activation) during normoxic and hypoxic conditions.
It is anticipated that these studies will provide basic information
regarding the role of oxygen radicals and their scavengers in injury due to
microemboli as well as the role of oxygen radicals generated by xanthine
oxidase in ischemic lung tissue.
成人呼吸窘迫综合征(ARDS)的特点是最初
肺微血管系统的渗透性增加。 在ARDS中,
可能涉及白细胞血小板氧气
自由基、胰头素、补体激活和血管内
凝血和纤维蛋白溶解。 血小板-纤维蛋白
人和实验动物肺中的栓塞和白细胞抑制栓塞
已经将注意力集中在微栓子上,并导致他们使用
急性肺损伤的实验模型。 虽然超氧化物的作用
和其他氧自由基已被描述在氧毒性,其作用
由于肺微血栓而造成的伤害很少受到关注
这是本研究的总体目标。
离体、灌注的狗肺标记将是基本的实验性标记。
准备. 这种制剂的优点是:1)它灌注有
全血及其所有成分,2)叶的重量是
连续监测和规定的微血管通透性指数
(Kf可以计算Pci),以及3)动脉、静脉和气道
可以独立地调节压力以将叶片保持在区域3中。
这一准备工作还将扩大有关影响的意见,
先前在完整肺制备物中制备的微栓子。
具体目的是1)表征渗透性的变化,
血管压力,以及微栓塞后血液的细胞成分,
2)确定氧清除剂-超氧化物的保护作用
歧化酶(SOD)、过氧化氢酶(CAT)、二甲基硫脲(DMTU)和
二甲基亚砜(DMSO),3)描述的保护作用,
观察别嘌呤醇预处理对粒细胞减少症的影响,
将它们与黄嘌呤氧化酶的组织水平相关联,以及5)
表征氧自由基对肺的直接影响,
氧清除剂的保护作用。 肺部会被栓塞
气泡(直径小于1 mm)、玻璃珠(50、200和500
和白细胞聚集体(由补体诱导
活化)。
预计这些研究将提供基本信息,
关于氧自由基及其清除剂在损伤中的作用
以及黄嘌呤产生的氧自由基的作用
缺血肺组织中的氧化酶。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pulmonary vascular permeability and resistance measurements in control and ANTU-injured dog lungs.
对照组和 ANTU 损伤狗肺的肺血管通透性和阻力测量。
- DOI:10.1152/ajpheart.1989.256.6.h1711
- 发表时间:1989
- 期刊:
- 影响因子:0
- 作者:Allison,RC;Rippe,B;Prasad,VR;Parker,JC;Taylor,AE
- 通讯作者:Taylor,AE
Protective effects of O2 radical scavengers and adenosine in PMA-induced lung injury.
O2 自由基清除剂和腺苷对 PMA 诱导的肺损伤的保护作用。
- DOI:10.1152/jappl.1988.64.5.2175
- 发表时间:1988
- 期刊:
- 影响因子:0
- 作者:Allison,RC;Hernandez,EM;Prasad,VR;Grisham,MB;Taylor,AE
- 通讯作者:Taylor,AE
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD C ALLISON其他文献
RONALD C ALLISON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD C ALLISON', 18)}}的其他基金
PULMONARY MICROEMBOLI: THE ROLE OF OXYGEN RADICALS
肺微栓塞:氧自由基的作用
- 批准号:
3087163 - 财政年份:1984
- 资助金额:
$ 7.56万 - 项目类别:
PULMONARY MICROEMBOLI: THE ROLE OF OXYGEN RADICALS
肺微栓塞:氧自由基的作用
- 批准号:
3087161 - 财政年份:1984
- 资助金额:
$ 7.56万 - 项目类别:
PULMONARY MICROEMBOLI: THE ROLE OF OXYGEN RADICALS
肺微栓塞:氧自由基的作用
- 批准号:
3087162 - 财政年份:1984
- 资助金额:
$ 7.56万 - 项目类别:
相似国自然基金
Apocynin和allopurinol对运动上调自发性高血压大鼠肾脏一氧化氮合成酶表达的影响
- 批准号:81301667
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Allopurinol Improves Diastolic Function in African Americans with Resistant Hypertension
别嘌呤醇可改善患有难治性高血压的非裔美国人的舒张功能
- 批准号:
10701217 - 财政年份:2023
- 资助金额:
$ 7.56万 - 项目类别:
Association Between Allopurinol and Cardiovascular Events, Mortality and End-Stage Renal Disease in Diabetes
别嘌呤醇与糖尿病心血管事件、死亡率和终末期肾病之间的关联
- 批准号:
377029 - 财政年份:2017
- 资助金额:
$ 7.56万 - 项目类别:
Fellowship Programs
CKD-FIX: a randomised, controlled trial of allopurinol in the slowing of kidney disease progression
CKD-FIX:别嘌呤醇减缓肾脏疾病进展的随机对照试验
- 批准号:
nhmrc : GNT1043203 - 财政年份:2013
- 资助金额:
$ 7.56万 - 项目类别:
Project Grants
PERL: A multi-center clinical trial of allopurinol to prevent GFR loss in T1D
PERL:别嘌呤醇预防 T1D 患者 GFR 损失的多中心临床试验
- 批准号:
9738022 - 财政年份:2013
- 资助金额:
$ 7.56万 - 项目类别:
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
PERL:别嘌呤醇预防 T1D 患者 GFR 损失的多中心临床试验
- 批准号:
8644403 - 财政年份:2013
- 资助金额:
$ 7.56万 - 项目类别:
A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
别嘌呤醇预防 1 型糖尿病 GFR 损失的多中心临床试验
- 批准号:
8445008 - 财政年份:2012
- 资助金额:
$ 7.56万 - 项目类别:
Design of a Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
别嘌呤醇预防 1 型糖尿病 GFR 损失的多中心临床试验设计
- 批准号:
8250159 - 财政年份:2011
- 资助金额:
$ 7.56万 - 项目类别:
Analysis of the mechanisms of allopurinol-induced severe cutaneous adverse reactions
别嘌呤醇致严重皮肤不良反应的机制分析
- 批准号:
23790611 - 财政年份:2011
- 资助金额:
$ 7.56万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
ALLOPURINOL AND CARDIAC FUNCTION IN IDIOPATHIC DILATED CARDIOMYOPATHY
特发性扩张型心肌病中别嘌呤醇与心脏功能
- 批准号:
7199117 - 财政年份:2004
- 资助金额:
$ 7.56万 - 项目类别:
ALLOPURINOL AND THE PREVENTION OF DEATH, TISSUE INJURY, AND SEIZURES IN CHD
别嘌呤醇与预防冠心病死亡、组织损伤和癫痫发作
- 批准号:
6116864 - 财政年份:1998
- 资助金额:
$ 7.56万 - 项目类别: